Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence โ Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022โ2025 | Base Year: 2025 | Forecast Period: 2026โ2034 |
|---|---|
| Product Type Segment | Fillable needle free injectors, Prefillable needle free injectors |
| Usability Segment | Disposable needle free injectors, Reusable needle free injectors |
| Site of Treatment Segment | Intradermal injectors, Intramuscular injectors, Subcutaneous injectors |
|---|---|
| Application Segment | Vaccination, Insulin Delivery, Pain Management, Hormone Replacement |
| Technology Segment | Gas Propelled, Spring Loaded, Vibration Enabled |
| End Use Segment | Hospital, Clinics, Homecare, Others |
| Distribution Channel Segment | Online, Offline |
| Regions & Countries |
|
Country-level data ยท Company profiles ยท Editable dataset ยท Analyst consultation included.
Charts are illustrative โ exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
PharmaJet announced that the World Health Organisation (WHO) had selected its Tropis Needle-free Injection System (NFIS) for large polio vaccination programmes. The firm developed and sold an intradermal needle-free platform to more effectively administer pharmaceuticals and biologics. Over 2.7 million children have been the target of this programme with the PharmaJet Tropis NFIS.
The information of patients such as injection time, frequency, dosage get collected in devices that possess a cloud-based platform, this helps the physician to understand the effect of the medication and its dosage on the patient.
PharmaJet, a company that created and sold a needle-free platform to more efficiently administer medications and biologics, today announced that the National Institutes of Health (NIH) had awarded them a direct-to-Phase II grant worth more than $800,000 to study the immunogenicity of intradermal administration.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| PharmaJet (US) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Portal Instruments (US) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Medical International Technology | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Inc (MIT) (US) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| NuGen Medical Devices (Canada) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Crossject SA (US) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Bioject Medical Technologies (US) | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation โThe market size was valued at USD 24.6 billion in 2022 and will be USD 59.7 billion till 2030 growing with a CAGR of 1.2% during the forecast period.
Needle free injection systems are injections that deliver medication into the bloodstream without the use of a needle. Needle free injection systems use a narrow stream of fluid to precisely dose and pierce the skin to deliver a spring-powered injection in seconds. External power and needle are not required. Needle free injection systems are the most efficient route of administration. The needle free injection system provides advanced technology that helps physicians to provide medication without piercing patients skin. Growing elderly population, increasing chronic disease, improving drug delivery system and growing demand in self-injectable devices are the prime drivers of the Needle-Free Injection System.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Needle Free Injection System Market Analysis is witnessing significant growth in the near future.
In 2023, the Fillable needle free injectors segment accounted for a notable share of the Needle Free Injection System Market Analysis.
★ Reviews
Rate this report
| Product Type | Fillable needle free injectors, Prefillable needle free injectors |
| Usability | Disposable needle free injectors, Reusable needle free injectors |
| Site of Treatment | Intradermal injectors, Intramuscular injectors, Subcutaneous injectors |
| Application | Vaccination, Insulin Delivery, Pain Management, Hormone Replacement |
| Technology | Gas Propelled, Spring Loaded, Vibration Enabled |
| End Use | Hospital, Clinics, Homecare, Others |
| Distribution Channel | Online, Offline |
| List of Competitors | PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), Bioject Medical Technologies (US) |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truthโข" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Needle Free Injection System Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Needle Free Injection System Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the needle free injection system market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need โ and we will tailor the deliverable to your requirements.